Propanc Biopharma, Inc. Note Agreements

116 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Promissory Note dated March 11, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated February 7, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated January 31, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated December 4, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Convertible Promissory Note dated December 15, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated September 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated August 2, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated June 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Convertible Promissory Note dated June 10, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Convertible Promissory Note dated May 22, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Convertible Promissory Note dated April 12, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated March 1, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Convertible Promissory Note dated December 8, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Convertible Promissory Note dated November 29, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Promissory Note, dated October 20, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Redeemable Note, dated October 12, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Redeemable Note, dated August 23, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Promissory Note, dated August 16, 2023, issued to the August Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
10% Original Issue Discount Promissory Note, dated August 15, 2023, issued to the August Lender
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Promissory Note, dated July 19, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Promissory Note, dated June 29, 2023, issued to the June Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Note, dated November 3, 2022, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
10% Convertible Redeemable Note, dated February 14, 2023, issued by the Company to ONE44 Capital LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Promissory Note, dated October 6, 2022, issued by the Company to Red Road Holdings Corporation
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Redeemable Note, dated September 21, 2022, issued by the Company to GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
10% Convertible Redeemable Note, dated August 15, 2022, issued by the Company to ONE44 Capital LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
8% Convertible Redeemable Note, dated August 12, 2022, issued by the Company to GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
8% Convertible Promissory Note, dated June 30, 2022, issued by the Company to 1800 Diagonal Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Promissory Note, dated May 12, 2022, issued by the Company to 1800 Diagonal Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Promissory Note, dated April 12, 2022, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
10% Convertible Redeemable Note, dated March 29, 2022, issued by the Company to ONE44 Capital LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
8% Convertible Promissory Note, dated March 7, 2022, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Promissory Note, January 3, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
10% Convertible Promissory Note, dated December 7, 2021, issued by the Company to ONE44 Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2021
8% Convertible Promissory Note, dated November 26, 2021, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
8% Convertible Promissory Note, dated October 21, 2021, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
8% Convertible Promissory Note, dated January 5, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021